Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03043313
Title Tucatinib Plus Trastuzumab in Patients With HER2+ Colorectal Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Seattle Genetics, Inc.
Indications

rectum adenocarcinoma

colon adenocarcinoma

Therapies

Trastuzumab + Tucatinib

Tucatinib

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | BEL

Additional content available in CKB BOOST